Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cyclerion Therapeutics (CYCN) Exchange Rate Effect (2019 - 2024)

Historic Exchange Rate Effect for Cyclerion Therapeutics (CYCN) over the last 6 years, with Q2 2024 value amounting to -$2000.0.

  • Cyclerion Therapeutics' Exchange Rate Effect fell 16666.67% to -$2000.0 in Q2 2024 from the same period last year, while for Mar 2025 it was -$2000.0, marking a year-over-year decrease of 16666.67%. This contributed to the annual value of -$6000.0 for FY2024, which is 17500.0% down from last year.
  • Cyclerion Therapeutics' Exchange Rate Effect amounted to -$2000.0 in Q2 2024, which was down 16666.67% from -$4000.0 recorded in Q1 2024.
  • In the past 5 years, Cyclerion Therapeutics' Exchange Rate Effect ranged from a high of $8000.0 in Q4 2022 and a low of -$12000.0 during Q2 2020
  • For the 5-year period, Cyclerion Therapeutics' Exchange Rate Effect averaged around $142.86, with its median value being $1000.0 (2021).
  • Its Exchange Rate Effect has fluctuated over the past 5 years, first surged by 40000.0% in 2023, then tumbled by 50000.0% in 2024.
  • Over the past 5 years, Cyclerion Therapeutics' Exchange Rate Effect (Quarter) stood at $3000.0 in 2020, then changed by 0.0% to $3000.0 in 2021, then skyrocketed by 166.67% to $8000.0 in 2022, then tumbled by 50.0% to $4000.0 in 2023, then plummeted by 150.0% to -$2000.0 in 2024.
  • Its Exchange Rate Effect was -$2000.0 in Q2 2024, compared to -$4000.0 in Q1 2024 and $4000.0 in Q4 2023.